Genomma Lab Internacional. de Balance Sheet Health
Financial Health criteria checks 5/6
Genomma Lab Internacional. de has a total shareholder equity of MX$9.8B and total debt of MX$6.2B, which brings its debt-to-equity ratio to 63.7%. Its total assets and total liabilities are MX$21.3B and MX$11.5B respectively. Genomma Lab Internacional. de's EBIT is MX$3.3B making its interest coverage ratio 4.7. It has cash and short-term investments of MX$968.6M.
Key information
63.7%
Debt to equity ratio
Mex$6.23b
Debt
| Interest coverage ratio | 4.7x |
| Cash | Mex$968.63m |
| Equity | Mex$9.77b |
| Total liabilities | Mex$11.54b |
| Total assets | Mex$21.31b |
Recent financial health updates
These 4 Measures Indicate That Genomma Lab Internacional. de (BMV:LABB) Is Using Debt Reasonably Well
May 31
Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly
Jan 29Is Genomma Lab Internacional. de (BMV:LABB) Using Too Much Debt?
Mar 31Does Genomma Lab Internacional. de (BMV:LABB) Have A Healthy Balance Sheet?
Dec 07Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet
Jul 27Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly
Mar 22Recent updates
These 4 Measures Indicate That Genomma Lab Internacional. de (BMV:LABB) Is Using Debt Reasonably Well
May 31Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly
Jan 29Is Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Trading At A 49% Discount?
Nov 07Is Genomma Lab Internacional. de (BMV:LABB) Using Too Much Debt?
Mar 31Is Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Trading At A 32% Discount?
Feb 24Does Genomma Lab Internacional. de (BMV:LABB) Have A Healthy Balance Sheet?
Dec 07Rainbows and Unicorns: Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Analysts Just Became A Lot More Optimistic
Sep 24Analysts Just Made A Major Revision To Their Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Revenue Forecasts
Aug 01Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet
Jul 27Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly
Mar 22Are Investors Undervaluing Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) By 44%?
Feb 15Genomma Lab Internacional. de (BMV:LABB) Seems To Use Debt Quite Sensibly
Nov 24Here's Why I Think Genomma Lab Internacional. de (BMV:LABB) Is An Interesting Stock
Sep 08Genomma Lab Internacional, S.A.B. de C.V.'s (BMV:LABB) Intrinsic Value Is Potentially 96% Above Its Share Price
Jun 10Is Genomma Lab Internacional. de (BMV:LABB) A Risky Investment?
May 24Should You Be Adding Genomma Lab Internacional. de (BMV:LABB) To Your Watchlist Today?
May 06Investors Who Bought Genomma Lab Internacional. de (BMV:LABB) Shares Five Years Ago Are Now Up 65%
Mar 13Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet
Feb 19Do Its Financials Have Any Role To Play In Driving Genomma Lab Internacional, S.A.B. de C.V.'s (BMV:LABB) Stock Up Recently?
Feb 02Are Investors Undervaluing Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) By 42%?
Jan 15What Is The Ownership Structure Like For Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB)?
Dec 28Genomma Lab Internacional. de (BMV:LABB) Shareholders Have Enjoyed A 54% Share Price Gain
Dec 10
Financial Position Analysis
Short Term Liabilities: LAB B's short term assets (MX$11.1B) exceed its short term liabilities (MX$6.9B).
Long Term Liabilities: LAB B's short term assets (MX$11.1B) exceed its long term liabilities (MX$4.7B).
Debt to Equity History and Analysis
Debt Level: LAB B's net debt to equity ratio (53.8%) is considered high.
Reducing Debt: LAB B's debt to equity ratio has reduced from 79% to 63.7% over the past 5 years.
Debt Coverage: LAB B's debt is well covered by operating cash flow (29.1%).
Interest Coverage: LAB B's interest payments on its debt are well covered by EBIT (4.7x coverage).